https://www.orthoworld.com
ORTHOWORLD
Smith+Nephew Prepared to Capitalize on ASC Acceleration
By Mike Evers

The company's orthopedic sales fell -34% in 2Q20, but Smith+Nephew is strategically positioned to benefit from the acceleration in ASC procedures.